SnapShot: Acute Myeloid Leukemia

20%-25% (28%-35%); High blast count; Poor prognosisespecially in cases with high mutant to WT allelic ratio5%-7% (10%-14%); Prognostic impact remains controversial10% (9%-14%); Enriched in CBF AML; Prognosis unknown<5% (<5%); 25-30% in CBF leukaemia<2% (2%); Prognosis unknown25%-30% (40%-65%); M4 blast morphology lacks CD34 expression; Hox gene upregulation; Favorable prognosis inthe presence...